Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Cybersecurity Demand US Accelerates AI Integration in Asia Following TrumpXi Summit Senior Official Says Nvidia Slumps After Earnings Beat Data Center Demand Surge Fuels Market Caution BlockCon Punta Cana Web3 iGaming and Finance Summit Explores Industry Convergence Goldman Sachs CEO David Solomon AIDriven Job Loss Fears Overblown May Create New Opportunities UK Social Media Regulation Risk Intensifies as Starmer Vows Action Following Meeting with Bereaved Parents PROP Q1 2026 Earnings Massive EPS Miss as Stock Rises 905 Amid Lack of Revenue Disclosure PLAB Q1 2026 Earnings EPS Beat Drives Stock Higher Sera Prognostics Q1 2026 Earnings EPS Meets Estimates as Stock Rises 15 on Operational Progress YPF Q4 2025 Earnings Massive Reported Loss Amidst Macro Turbulence XBIO Q2 2025 Earnings EPS Beat Estimates but Stock Slips on Continued Cash Burn AL Q4 2025 Earnings EPS Surges Past Estimates by 239 Victory Capital Holdings VCTR Holds Steady Near Resistance Key Levels to Watch Syndax Pharmaceuticals SNDX Holds Steady Near 20 as Market Watches Key Levels Chime Financial CHYM Faces Resistance Pressure as Stock Declines 178 Phoenix Asia Holdings Surges 17 Testing Key Resistance Levels Wheeler Real Estate Investment Trust WHLR Rallies 49 to 107 Testing Key Resistance Germany Resists EU Pressure for Tougher China Stance as Trade Minister Visits Beijing KLIC Q1 2026 Earnings EPS Surprises by 157 but Stock Declines amid Uncertain Revenue Outlook WF International WXM Edges Higher Resistance and Support Levels in Focus ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status EVAX Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development RCON Q4 2025 Earnings NarrowerThanExpected Loss Drives Optimism Despite Revenue Void ARKO Petroleum Corp Q1 2026 Earnings EPS Beat Despite Challenging Operating Environment EMN Q1 2026 Earnings Earnings Per Share Beats Estimates Stock Edges Higher ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Autolus Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline